SOLEFUL 1

  • Research type

    Research Study

  • Full title

    Extracorporeal Shockwave Therapy for Diabetic Foot Ulcers: A Pilot 3-Arm Randomised Control Trial and Qualitative Study (SOLEFUL)

  • IRAS ID

    311664

  • Contact name

    Louise Hitchman

  • Contact email

    l.hitchman@nhs.net

  • Sponsor organisation

    Hull University Teaching Hospital NHS Trust

  • Clinicaltrials.gov Identifier

    NCT05380544

  • Clinicaltrials.gov Identifier

    Worktribe, 3660370; NIHR, 301807

  • Duration of Study in the UK

    10 years, 0 months, 0 days

  • Research summary

    Diabetes foot ulcers affect 25% of people with diabetes and often fail to heal. This is associated with amputation and death. Extracorporeal shockwave therapy (high power soundwaves) is a non-invasive treatment that is delivered directly to the ulcer and may improve healing. However, the effectiveness of shockwave therapy and the optimum dose is unknown.

    The aim of this study is to:
    - Carry out a preliminary (pilot) trial comparing sham (not active) shockwave therapy, low number of shockwaves and high number of shockwaves on diabetes foot ulcers
    - To understand beliefs, concerns, ideas and experience of shockwave therapy amongst patients and clinicians
    The research has been co-designed by patients and their families with experience of diabetic foot ulcers.

    Pilot Trial:
    Ninety patients who have a diabetic foot ulcer will be randomly assigned to one of the three treatment groups:
    - High dose shockwave therapy
    - Low dose shockwave therapy
    - ‘Sham’ shockwave therapy
    Each treatment will be delivered in a 3x30minute sessions over a 7 day period. All patients will receive usual ulcer care. Face to face follow up appointments will be at 6 weeks, 12 weeks and 24 weeks after study entry to measure ulcer healing, changes in quality of life and health resource use.

    Interviews:
    Informal interviews, lasting around 30minutes, will be undertaken to explore patient opinion of shockwave therapy, experience of taking part in the trial, reasons patients do not want to take part and clinician attitudes to shockwave therapy. 24 patients and 8 clinicians will be invited to take part.

  • REC name

    Wales REC 4

  • REC reference

    22/WA/0089

  • Date of REC Opinion

    12 Apr 2022

  • REC opinion

    Favourable Opinion